论文部分内容阅读
选取2013年6月~12月我院收治的200例脑血栓患者。随机分为对照组和研究组各100例。对照组采取舒血宁注射液治疗,研究组采取疏血通注射液治疗,比较两组治疗效果和DNS评分情况。结果两组患者接受治疗后,均未见明显不良反应两组治疗总有效率相比,差异无统计学意义(P>0.05);研究组患者DNS评分与对照组相比,差异不明显,无统计学意义(P>0.05)。舒血宁注射液与疏血通注射液治疗脑血栓疗效相当,具有积极的临床研究和推广价值。
Select 200 cases of cerebral thrombosis admitted to our hospital from June to December 2013. Randomly divided into control group and study group of 100 cases. The control group to take Shuxuening injection, the study group to Shuxuetong injection treatment, the treatment effect and DNS scores were compared. Results There was no significant adverse reaction in both groups after treatment. There was no significant difference in the total effective rate between the two groups (P> 0.05). There was no significant difference between the two groups in the DNS score and the control group Statistical significance (P> 0.05). Shuxuening injection and Shuxuetong injection treatment of cerebral thrombosis comparable, with a positive clinical research and promotion of value.